Anticancer phototherapy using activation of E-combretastatins by two-photon–induced isomerization
暂无分享,去创建一个
Kathrin M Scherer | Roger H Bisby | Stanley W Botchway | John A Hadfield | Anthony W Parker | S. Botchway | A. Parker | J. Hadfield | R. Bisby | K. Scherer
[1] M. Maynadier,et al. Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors. , 2011, Angewandte Chemie.
[2] David Kessel,et al. Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.
[3] S. Botchway,et al. Fluorescence lifetime imaging of E-combretastatin uptake and distribution in live mammalian cells. , 2012, European journal of cancer.
[4] W. Webb,et al. Multiphoton fluorescence excitation: new spectral windows for biological nonlinear microscopy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[5] S. Botchway,et al. Laser-induced radiation microbeam technology and simultaneous real-time fluorescence imaging in live cells. , 2012, Methods in enzymology.
[6] A. Ustione,et al. A simple introduction to multiphoton microscopy , 2011, Journal of microscopy.
[7] S. Botchway,et al. Spectroscopy and fluorescence lifetime imaging in live cells of a cyano-substituted combretastatin , 2014 .
[8] K. Flaherty,et al. Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin , 2005, Clinical Cancer Research.
[9] H. Kuhn,et al. Cis‐Trans Photoisomerization of Stilbenes and Stilbene‐Like Molecules , 2007 .
[10] Mamta Khurana,et al. Quantitative In Vitro Demonstration of Two‐Photon Photodynamic Therapy Using Photofrin® and Visudyne® , 2007, Photochemistry and photobiology.
[11] E. Schwartz. Antivascular Actions of Microtubule-Binding Drugs , 2009, Clinical Cancer Research.
[12] N. Lawrence,et al. Structural requirements for the interaction of combretastatins with tubulin: how important is the trimethoxy unit? , 2003, Organic & biomolecular chemistry.
[13] T. Ganesan,et al. A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer , 2010, British Journal of Cancer.
[14] R. Cubeddu,et al. In vivo optical characterization of human tissues from 610 to 1010 nm by time-resolved reflectance spectroscopy. , 2001, Physics in medicine and biology.
[15] M. Drobizhev,et al. Vascular targeting to the SST2 receptor improves the therapeutic response to near-IR two-photon activated PDT for deep-tissue cancer treatment. , 2013, Biochimica et biophysica acta.
[16] G. Tozer,et al. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. , 1997, Cancer research.
[17] Hazel A. Collins,et al. Two-photon absorption and the design of two-photon dyes. , 2009, Angewandte Chemie.
[18] Aleksander Rebane,et al. Blood-vessel closure using photosensitizers engineered for two-photon excitation , 2008 .
[19] A. Boulares,et al. Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4. , 1998, Cancer research.
[20] Aleisha Elliott,et al. New Two-Photon Activated Photodynamic Therapy Sensitizers Induce Xenograft Tumor Regressions after Near-IR Laser Treatment through the Body of the Host Mouse , 2008, Clinical Cancer Research.
[21] Kinetics of reversible photoisomerization: determination of the primary quantum yields for the E-Z photoisomerization of silylenephenylenevinylene derivatives. , 2009, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[22] N. Lawrence,et al. Synthesis and anticancer activity of fluorinated analogues of combretastatin A-4 , 2003 .
[23] M. Horsman,et al. Combretastatin-induced hypertension and the consequences for its combination with other therapies. , 2011, Vascular pharmacology.